Primary mitochondrial myopathies in childhood.
Catarina Olimpio1, May Yung Tiet2, Rita Horvath2
1East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
Neuromuscular Disorders : NMD
|November 5, 2021
Summary
Primary mitochondrial myopathies are common inherited metabolic disorders in children, affecting skeletal muscle due to mitochondrial dysfunction. Early diagnosis via muscle biopsy and genetic testing is crucial for managing symptoms and exploring targeted treatments.
Area of Science:
- Biochemistry
- Genetics
- Pediatrics
Background:
- Primary mitochondrial myopathies are genetic metabolic disorders impacting skeletal muscle function.
- These are the most common inherited metabolic disorders in childhood, often mimicking other muscle diseases.
- Diagnosis requires muscle biopsy and genetic testing for accurate differentiation.
Purpose of the Study:
- To review the clinical presentation and genetic causes of primary mitochondrial myopathies in children.
- To highlight the importance of differential diagnosis in childhood muscle diseases.
- To discuss current and emerging targeted treatment strategies.
Main Methods:
- Literature review of primary mitochondrial myopathies in childhood.
- Analysis of clinical features, genetic etiologies, and diagnostic approaches.
- Examination of therapeutic interventions for specific genetic defects.
Main Results:
- Childhood-onset myopathies often involve significant skeletal muscle impact and stem from nuclear DNA gene defects.
- Infantile presentations include hypotonia and feeding difficulties; older children show developmental delays and exercise intolerance.
- Specific gene defects affect mitochondrial functions like oxidative phosphorylation and fusion/fission.
Conclusions:
- Primary mitochondrial myopathies are a diverse group of genetic disorders requiring precise diagnosis.
- Targeted therapies, such as riboflavin and deoxynucleosides, show promise for specific mitochondrial myopathies.
- Further research into genetic causes and treatment is essential for improving patient outcomes.
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
2.1K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.1K
Animal Mitochondrial Genetics
8.3K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
8.3K
Disorders of the Skeletal Muscle
1.3K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.3K
ATP Synthase: Mechanism
15.5K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
15.5K
Myasthenia Gravis: Diagnostic Tests
1.5K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.5K
Inborn Errors of Metabolism
328
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
328


